A Double Blind, Randomized, Placebo Controlled, Parallel Group Study to Investigate the Effect of ATI-7505 [naronapride] on Gastric Emptying and Small Bowel and Colonic Transit in Healthy Volunteers.
Phase of Trial: Phase I/II
Latest Information Update: 02 Apr 2010
At a glance
- Drugs Naronapride (Primary)
- Indications Constipation; Gastro-oesophageal reflux; Non-ulcer dyspepsia
- Focus Pharmacodynamics
- 02 Apr 2010 New trial record